Knowledge gaps in the 2024 consensus statement on atrial fibrillation ablation: read the news in #EHJ! #EHJ #cardiotwitter #atrial #fibrillation #gaps #evidence @ESC_journals European Society of Cardiology

Great work with our team investigating the role of SGLT2i in patients with HFpEF after acute MI in a real-world setting using TriNetX. Tess Calcagno MD, PharmD venu menon DebbieKwonMD W. H. Wilson Tang, MD Tom Wang MBChB MD

Today marked my last day at STJ and the end of my PGY-2 year. Very excited to begin my PhD in the PRISM program. Feeling grateful to Andrei Brateanu & CCF IMRP for this incredible opportunity. Here’s to new beginnings and future adventures! 💙💚#WIC #PRISM #AFGen Cleveland Clinic IM

🏃🥗 Lifestyle matters—but not enough. In PRAGUE-25, #AFib freedom was 2x higher with ablation vs LFM+AADs. The heart wants what the EP lab offers. jacc.org/doi/10.1016/j.… #JACC #epAblation #Obesity

💥 Tacrolimus-induced TMA in OHT recepients, a rare but serious complication Read our recently published article in JACC Journals 👇🏻 jacc.org/doi/10.1016/j.… Grateful for my coauthors and mentors Randall Starling Rochell Issa (she/her) Tess Calcagno MD, PharmD

Amazing work with my favorite coresidents 🫀🫀🫀🫀🫶🏻

Excellent work with the best team! Faysal Massad, MD. (he/him) Tess Calcagno MD, PharmD

📢 New research Finerenone was linked to lower 1- and 3-year mortality in patients with HFpEF and HFmrEF in our real-world, propensity-matched analysis. Thankful to my amazing team 💙 Rochell Issa (she/her) , Faysal Massad, MD. (he/him) sciencedirect.com/science/articl… #CardioTwitter #HFpEF #MedTwitter

Excellent work again with the best team 🫀 Faysal Massad, MD. (he/him) Tess Calcagno MD, PharmD

America, the beautiful 📷: rebelroadphotos/IG

HAPPY 4TH!

After his third round win, Ben Shelton called on his elder sister Emma's employer to give her more PTO, as she'd been his 'lucky charm' this Wimbledon. The employer, Morgan Stanley, accepted. Emma was back in the stands today as Ben won his fourth round. Brother of the year 🙌

U.S. FDA Approves Finerenone for New Indication in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥ 40% Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved finerenone (Kerendia™), a non-steroidal, selective

I’m walking in the 2025 Greater Cleveland Heart Walk to raise money for heart disease research—something close to my heart. Women often face delays in diagnosis and care, and I want to help change that. If you can, please consider donating! 🫀 www2.heart.org/site/TR/HeartW…

We celebrate the retirement of Dr. Robert Mayock—brilliant clinician, gifted educator, and role model to generations of physicians. His decades of dedication to patient care and medical education have shaped our program and inspired generations. Thank you, Dr. Mayock! 💙

New research in Journal of Physiology shows sex itself, beyond size or age, shapes heart structure. These differences matter for diagnosis, treatment, and research. Equitable care requires sex-specific evidence. Read: physoc.onlinelibrary.wiley.com/doi/10.1113/JP… #WomenInCardiology #CardioTwitter

Adolescent Cardiovascular Risk Trajectories and Later Maternal Morbidity jamanetwork.com/journals/jaman… #CardioObstetrics

It's About Sex, Not Just Fat: Interpreting the Adipokine Hypothesis in the Context of Sex Differences in HFpEF women exhibit stronger associations between excess VAT and hemodynamic abnormalities, including elevated pulmonary capillary wedge pressure during exercise (indicative

Statin therapy during pregnancy. Read more in the @EHJ at doi.org/10.1093/eurhea… #PregnancyHealth #StatinTherapy #MaternalHealth #PregnancyCare @ESCardio European Society of Cardiology Journals

#ACCCardioOB #CardioObstetrics